Dr. Turka is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3400 Spruce St
210 White Building
Philadelphia, PA 19104Phone+1 215-662-2638Fax+1 215-349-5703
Education & Training
Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 1985 - 1988
Yale-New Haven Medical CenterResidency, Internal Medicine, 1983 - 1985- Yale-New Haven Medical CenterInternship, Internal Medicine, 1982 - 1983
Yale School of MedicineClass of 1982
Certifications & Licensure
PA State Medical License 1994 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Nephrology
Awards, Honors, & Recognition
- Whos Who in Medicine and Healthcare Marquis Whos Who
Clinical Trials
- Associating Renal Transplantation With the ITN Signature of Tolerance Start of enrollment: 2010 Sep 01
- A Cohort Study of Operationally Tolerant Allograft Recipients Start of enrollment: 2016 Jun 30
Publications & Presentations
PubMed
- 539 citationsIdentification of a B cell signature associated with renal transplant tolerance in humansKenneth A. Newell, Adam Asare, Allan D. Kirk, Trang D. Gisler, Kasia Bourcier
The Journal of Clinical Investigation. 2010-06-01 - 511 citationsMetabolic programming and PDHK1 control CD4+ T cell subsets and inflammationValerie A. Gerriets, Rigel J. Kishton, Amanda G. Nichols, Andrew N. Macintyre, Makoto Inoue
The Journal of Clinical Investigation. 2015-01-02 - 172 citationsNotch Signaling Augments T Cell Responsiveness by Enhancing CD25 ExpressionScott H. Adler, Elise Chiffoleau, Lanwei Xu, Nicole M. Dalton, Jennifer M. Burg
Journal of Immunology. 2003-09-15
Journal Articles
- Maintenance of CD4 T Cell Fitness Through Regulation of Foxo1Bruce R Blazar, Laurence A Turka, Nature
Press Mentions
Rubius Therapeutics to Participate in Guggenheim Healthcare Talks | 2021 Oncology DaysMay 15th, 2020
Biological 'Atlas' Shows Dual Personality for Immune Cells That Cause Type 1 DiabetesMarch 30th, 2020
Rubius Therapeutics Appoints Internationally Recognized Autoimmunity and Translational Immunology Leader Laurence Turka, M.D., as Chief Scientific OfficerJanuary 8th, 2020- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
